Skip to main content

Lecia V Sequist MD, MPH

Dr Lecia V Sequist is the Landry Family Associate Professor of Medicine at Harvard Medical School and Director of the Center for Innovation in Early Cancer Detection at Massachusetts General Hospital, Boston, USA.

She managed patients with lung cancer as well as pulmonary nodules, and her research focuses on both EGFR mutation-positive lung cancer and on technologies that further early detection of lung and other cancers.

She has published over 200 academic papers and held grants from the NIH, the DOD, and many private foundations.

print
PRINT

Latest contributions from Lecia V Sequist

28-04-2020 | AACR 2020 | News

Capmatinib shows potential for treatment of MET-driven NSCLC

The selective MET inhibitor capmatinib has antitumor activity in patients with advanced non-small-cell lung cancer harboring MET exon 14 mutations, including in those with brain metastases, suggest GEOMETRY mono-1 study results.